Abstract
Background
Nasopharyngeal carcinoma (NPC) is one of the malignant cancers in southern China. Phillyrin is a major active constituent extracted from Forsythia suspensa (Thunb.) and possesses anti-inflammatory and anti-tumor properties.
Objective
This study was conducted to clarify the functional role and mechanism of autophagy in the anti-tumor effects induced by phillyrin, as well as the combined effects of phillyrin and the autophagy inhibitor chloroquine (CQ).
Results
Phillyrin dose-dependently suppressed NPC cell viability, whereas promoted cell apoptosis. In addition, phillyrin induced autophagy in NPC cells by increasing Beclin-1 protein expression and LC3-II/I ratio as well as decreasing p62 protein level. Pathway analysis showed that phillyrin enhanced the phosphorylation levels of AMPK but inhibited the phosphorylation of mTOR and p70s6k. Furthermore, the combined use of phillyrin and CQ further suppressed CNE-1 cell viability and promoted cell apoptosis.
Conclusion
These findings indicate that inhibition of autophagy by CQ enhances phillyrin-mediated anti-tumor activity in vitro, which may provide a novel strategy to improving the anti-cancer efficacy of drug treatment.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Bensouda Y et al (2011) Treatment for metastatic nasopharyngeal carcinoma. Eur Ann Otorhinolaryngol Head Neck Dis 128:79–85
Bruce JP et al (2015) Nasopharyngeal cancer: molecular landscape. J Clin Oncol 33:3346–3355
Díaz Lanza AM et al (2001) Lignan and phenylpropanoid glycosides from Phillyrea latifolia and their in vitro anti-inflammatory activity. Planta Med 67:219–223
Dmitrieva-Posocco O et al (2019) Cell-type-specific responses to interleukin-1 control microbial invasion and tumor-elicited inflammation in colorectal cancer. Immunity 50:166-180.e7
Dong Y et al (2019) Inhibition of autophagy by 3-MA promotes hypoxia-induced apoptosis in human colorectal cancer cells. Eur Rev Med Pharmacol Sci 23:1047–1054
Du B et al (2019) Phillygenin exhibits anti-inflammatory activity through modulating multiple cellular behaviors of mouse lymphocytes. Immunopharmacol Immunotoxicol 41:76–85
Fang Y, Tan J, Zhang Q (2015) Signaling pathways and mechanisms of hypoxia-induced autophagy in the animal cells. Cell Biol Int 39:891–898
Galluzzi L et al (2017) Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol 14:247–258
Gong H (2021) Pinocembrin suppresses proliferation and enhances apoptosis in lung cancer cells in vitro by restraining autophagy. Bioengineered 12:6035–6044
Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23:2891–2906
Gump JM, Thorburn A (2011) Autophagy and apoptosis: what is the connection? Trends Cell Biol 21:387–392
Huang PJ et al (2021) Potential of antiviral drug oseltamivir for the treatment of liver cancer. Int J Oncol 59:1
Jarauta V et al (2016) Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo. Cancer Lett 382:1–10
Ji Y et al (2017) Deprivation of asparagine triggers cytoprotective autophagy in laryngeal squamous cell carcinoma. Appl Microbiol Biotechnol 101:4951–4961
Katano A et al (2018) Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: a retrospective study. Medicine (baltimore) 97:e0502
Lalaoui N, Lindqvist LM, Sandow JJ, Ekert PG (2015) The molecular relationships between apoptosis, autophagy and necroptosis. Semin Cell Dev Biol 39:63–69
Lee DG et al (2011) Lignans from the flowers of Osmanthus fragrans var. aurantiacus and their inhibition effect on NO production. Arch Pharm Res 34:2029–2035
Levine B, Kroemer G (2019) Biological functions of autophagy genes: a disease perspective. Cell 176:11–42
Li Y et al (2017) Anti-inflammatory effects of Shufengjiedu capsule for upper respiratory infection via the ERK pathway. Biomed Pharmacother 94:758–766
Li W et al (2018) Exploring MicroRNAs on NIX-dependent mitophagy. Methods Mol Biol 1759:111–121
Li X et al (2021a) CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression. Autophagy 17:4323–4340
Li Y et al (2021b) Nitric oxide alleviated high salt-induced cardiomyocyte apoptosis and autophagy independent of blood pressure in rats. Front Cell Dev Biol 9:646575
Liu H et al (2016) Emodin ameliorates cisplatin-induced apoptosis of rat renal tubular cells in vitro by activating autophagy. Acta Pharmacol Sin 37:235–245
Liu L et al (2021) Adiponectin attenuates lipopolysaccharide-induced apoptosis by regulating the Cx43/PI3K/AKT pathway. Front Pharmacol 12:644225
Luo CL et al (2021) RBFOX2/GOLIM4 splicing axis activates vesicular transport pathway to promote nasopharyngeal carcinogenesis. Adv Sci (weinh) 8:e2004852
Nawale L et al (2017) Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa. PLoS ONE 12:e0174241
Olivares-Urbano MA, Griñán-Lisón C, Marchal JA, Núñez MI (2020) CSC radioresistance: a therapeutic challenge to improve radiotherapy effectiveness in cancer. Cells 9:1651
Paredes-Juarez GA et al (2015) DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1. Sci Rep 5:14623
Perera RM, Bardeesy N (2015) Pancreatic cancer metabolism: breaking it down to build it back up. Cancer Discov 5:1247–1261
Puissant A, Fenouille N, Auberger P (2012) When autophagy meets cancer through p62/SQSTM1. Am J Cancer Res 2:397–413
Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L (2018) The autophagic network and cancer. Nat Cell Biol 20:243–251
Shao ZQ et al (2021) Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury. Neural Regen Res 16:1044–1051
Shui L et al (2020) Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway. Aging (albany) 12:24318–24332
Song L et al (2017) Natural cyclopeptide RA-XII, a new autophagy inhibitor, suppresses protective autophagy for enhancing apoptosis through AMPK/mTOR/P70S6K pathways in HepG2 cells. Molecules 22:1934
Wang DH, He X, He Q (2019) Combining use of Phillyrin and autophagy blocker alleviates laryngeal squamous cell carcinoma via AMPK/mTOR/p70S6K signaling. Biosci Rep 39:1
Wang X et al (2021) Death by histone deacetylase inhibitor quisinostat in tongue squamous cell carcinoma via apoptosis, pyroptosis, and ferroptosis. Toxicol Appl Pharmacol 410:115363
Wei KR et al (2017) Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer 36:90
White E (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12:401–410
Xiao Z, Chen Z (2019) Deciphering nasopharyngeal carcinoma pathogenesis via proteomics. Expert Rev Proteomics 16:475–485
Yang ZJ, Chee CE, Huang S, Sinicrope FA (2011) The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10:1533–1541
Yang YP et al (2013) Application and interpretation of current autophagy inhibitors and activators. Acta Pharmacol Sin 34:625–635
Yang C et al (2016) AstragalosideII inhibits autophagic flux and enhance chemosensitivity of cisplatin in human cancer cells. Biomed Pharmacother 81:166–175
Yang L et al (2017) Protective effect of phillyrin on lethal LPS-induced neutrophil inflammation in zebrafish. Cell Physiol Biochem 43:2074–2087
Zhang L et al (2020) IMCA induces ferroptosis mediated by SLC7A11 through the AMPK/mTOR pathway in colorectal cancer. Oxid Med Cell Longev 2020:1675613
Zhou C et al (2022a) Review on the pharmacological properties of phillyrin. Molecules 27:3670
Zhou Y et al (2022b) Membrane dynamics of ATG4B and LC3 in autophagosome formation. J Mol Cell Biol 13:853–863
Acknowledgements
The authors appreciate all the participants providing supports for this study.
Funding
The work was supported by Bengbu Medical College Natural Science Key Fund Funded Project (Approval No. 2020byzd142).
Author information
Authors and Affiliations
Contributions
YX were the main designers of this study. YX, CJ, ZC, WY, and SG performed the experiments and analyzed the data. YX and CJ drafted the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Yajia Xu declares that he has no conflict of interest. Chengyi Jiang declares that he has no conflict of interest. Zhongqiang Cheng declares that he has no conflict of interest. Weige Yao declares that she has no conflict of interest. Sichen Ge declares that she has no conflict of interest.
Ethical approval
Our study did not require an ethical board approval, because it did not contain human or animal trials.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Xu, Y., Jiang, C., Cheng, Z. et al. Combining use of phillyrin and autophagy blocker exerts suppressive effect on nasopharyngeal carcinoma cell malignancy and autophagy via AMPK/mTOR/p70s6k signaling pathway. Mol. Cell. Toxicol. (2023). https://doi.org/10.1007/s13273-023-00374-x
Accepted:
Published:
DOI: https://doi.org/10.1007/s13273-023-00374-x